Contact this trialFirst, we need to learn more about you.
YL201 for Solid Tumors
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing a new drug, YL201, to see if it is safe and effective in treating patients with advanced solid tumors. The trial will be conducted in two parts: a dose escalation part to find the maximum tolerated dose (MTD) or recommended dose (RED), followed by a dose expansion part to further study the safety and efficacy of YL201 at the MTD/RED.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.